NCT00485498View on ClinicalTrials.gov

Managing Acute Schizophrenia, a Comparison Between Two Atypical Antipsychotics

PHASE4CompletedINTERVENTIONAL

Enrollment

122

Participants

Timeline

Start Date

April 30, 2003

Study Completion Date

December 31, 2003

Conditions

Schizophrenia

Interventions

DRUG

Olanzapine Hydrochloride

DRUG

Risperidone

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Beijing

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT00485498 - Managing Acute Schizophrenia, a Comparison Between Two Atypical Antipsychotics | Biotech Hunter | Biotech Hunter